Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats.
Oskouei BG, Abbaspour-Ravasjani S, Jamal Musavinejad S, Ahmad Salehzadeh S, Abdolhosseinzadeh A, Hamishehkar H, Ghahremanzadeh K, Shokouhi B. Oskouei BG, et al. Drug Res (Stuttg). 2018 Aug 24. doi: 10.1055/a-0692-2171. Online ahead of print. Drug Res (Stuttg). 2018. PMID: 30142632 No abstract available.
Nanovehicles for co-delivery of anticancer agents.
Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR. Zeinali M, et al. Drug Discov Today. 2020 Aug;25(8):1416-1430. doi: 10.1016/j.drudis.2020.06.027. Epub 2020 Jul 2. Drug Discov Today. 2020. PMID: 32622880 Review.
Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis.
Cláudia Paiva-Santos A, Gama M, Peixoto D, Sousa-Oliveira I, Ferreira-Faria I, Zeinali M, Abbaspour-Ravasjani S, Mascarenhas-Melo F, Hamishehkar H, Veiga F. Cláudia Paiva-Santos A, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2022 Apr 25;618:121656. doi: 10.1016/j.ijpharm.2022.121656. Epub 2022 Mar 9. Int J Pharm. 2022. PMID: 35278601 Free article. Review.
Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Asadollahi L, Mahoutforoush A, Dorreyatim SS, Soltanfam T, Paiva-Santos AC, Peixoto D, Veiga F, Hamishehkar H, Zeinali M, Abbaspour-Ravasjani S. Asadollahi L, et al. Among authors: abbaspour ravasjani s. Int J Pharm. 2022 Aug 25;624:122027. doi: 10.1016/j.ijpharm.2022.122027. Epub 2022 Jul 16. Int J Pharm. 2022. PMID: 35850183
16 results